Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

DMD is a rare, lethal neuromuscular disorder characterized by progressive muscle weakness and wasting. It primarily affects boys, with an estimated incidence of 1 in 3600 male live births. 1 The ...

Test Your Knowledge About the Signs and Symptoms of FNAIT Test Your Knowledge About the Epidemiology of FNAIT Test Your Knowledge About the Diagnosis of FNAIT Rare Disease Advisor, a trusted source of ...

Physiotherapy is the best way to keep children with DMD on their feet as long as possible, but my grandson is just a boy who wants to play. Test Your Knowledge About the Comorbidities of DMD Test Your ...

Get the latest news, resources, and perspectives on idiopathic pulmonary fibrosis (IPF), written specifically for HCPs who treat the disease.

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

The term muscular dystrophy encompasses a group of genetic diseases characterized by progressive muscle weakness and wasting. There are different types of muscular dystrophy depending on genetic ...

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare blood condition that develops in the fetus or neonate during pregnancy or at birth in which maternal alloantibodies target paternally ...

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by chronically progressing lung fibrosis. The most common symptoms of IPF include exertional dyspnea and chronic, ...

The use of semaglutide has been associated with improvement of treatment-resistant mast cell activation symptoms in an overweight patient with SM. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) ...